Nilsine Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Nilsine Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$25.3M	Sell	93,058 -4,167	-4%	-$1.08M	1.76%	7
2026 Q2	$24.1M	Buy	97,225 +2,142	+2%	+$461K	1.67%	9
2026 Q1	$19.4M	Buy	95,083 +89,843	+1,715%	+$18.6M	1.52%	10
2025 Q4	$1.08M	Buy	+5,240	New	+$1.05M	0.09%	201
2024 Q1	–	Sell	-7,283	Closed	-$1.15M	–	340
2023 Q4	$1.15M	Buy	7,283 +191	+3%	+$27.4K	0.18%	145
2023 Q3	$1.04M	Buy	7,092 +119	+2%	+$18.1K	0.16%	159
2023 Q2	$1.07M	Sell	6,973 -55	-0.8%	-$8.58K	0.16%	160
2023 Q1	$1.09M	Buy	+7,028	New	+$1.1M	0.17%	155

Other funds holding FBT

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return

Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return

B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Nilsine Partners's FBT Position: Q3 2026 in Review

Nilsine Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.3% in Q3 2026, selling an estimated $1.08M and leaving 93,058 shares worth $25.3M. The position accounts for 1.76% of the portfolio, ranked #7.

Nilsine Partners first reported a position in FBT in Q1 2023 and has held it in 8 quarters since. 151 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Nilsine Partners held 93,058 shares of First Trust NYSE Arca Biotechnology Index Fund worth $25.3M as of Q3 2026.
Nilsine Partners sold 4,167 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $1.08M.
First Trust NYSE Arca Biotechnology Index Fund made up 1.76% of Nilsine Partners's portfolio in Q3 2026, its #7 holding.
Nilsine Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and has held it in 8 quarters since.
151 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.